Warburg-like Metabolic Reprogramming in Endometriosis: From Molecular Mechanisms to Therapeutic Approaches
Pharmaceuticals · 28.05.2025 · 18 (6) · 813
DOI: 10.3390/ph18060813 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 28.05.2025. Verfasst von Bo-Sung Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grants funded by the Korean government (MIST), National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Endometriosis is a chronic gynecological disorder characterized by the presence of endometrial-like tissue outside the uterus, leading to inflammation, pain, and infertility. Emerging evidence indicates that endometriotic lesions exhibit cancer-like properties, including metabolic reprogramming marked by increased glucose uptake, enhanced Warburg’s effect, and altered mitochondrial function. These metabolic adaptations support cell survival under hypoxic conditions and contribute to immune evasion and sustained proliferation. This review summarizes current findings on the molecular mechanisms driving metabolic reprogramming in endometriosis, including the roles of mitochondrial dysfunction, hypoxia-inducible factor (HIF) signaling, the PI3K/AKT/mTOR pathway, inflammatory cytokines, and genetic and epigenetic regulators. In addition, we discuss therapeutic strategies targeting glycolytic pathways using both synthetic inhibitors and natural compounds, which represent promising non-hormonal options. Finally, we highlight the need for further preclinical and clinical studies to validate metabolic interventions and improve outcomes for patients with endometriosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Institute for Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
- Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
- Department of Molecular Biology and Immunology, Kosin University College of Medicine, Busan 49267, Republic of Korea.
- Department of Obstetrics and Gynecology, School of Medicine, Pusan National University Hospital, Busan 49241, Republic of Korea.
- Division of Pharmacology, School of Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
ORCID-Profile: Bosung Kim, Wonyoung Park, Sung-Jin Bae, Jongkil Joo, Ki-Tae Ha
Förderung
- National Research Foundation of Korea (NRF) grants funded by the Korean government (MIST)
- National Research Foundation of Korea (NRF)
Zitieren
APA
Kim, B. S., Kim, B., Yoon, S., Park, W., Bae, S. J., Joo, J., Kim, W., & Ha, K. T. (2025). Warburg-like Metabolic Reprogramming in Endometriosis: From Molecular Mechanisms to Therapeutic Approaches. Pharmaceuticals, 18(6), 813. https://doi.org/10.3390/ph18060813
Vancouver
Kim BS, Kim B, Yoon S, Park W, Bae SJ, Joo J, et al. Warburg-like Metabolic Reprogramming in Endometriosis: From Molecular Mechanisms to Therapeutic Approaches. Pharmaceuticals. 2025;18(6):813. doi:10.3390/ph18060813
BibTeX
@article{Kim2025,
author = {Kim, Bo-Sung and Kim, Bosung and Yoon, Seyeong and Park, Wonyoung and Bae, Sung-Jin and Joo, Jongkil and Kim, Wonnam and Ha, Ki-Tae},
title = {Warburg-like Metabolic Reprogramming in Endometriosis: From Molecular Mechanisms to Therapeutic Approaches},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {6},
pages = {813},
doi = {10.3390/ph18060813}
}
EUVIMED